What lies ahead for the Glomerulonephritis market? | Asian Business Review
Photo from Envato

What lies ahead for the Glomerulonephritis market?

Ongoing clinical trial activities drive market growth.

The Glomerulonephritis market is expected to surge by 2034, amidst the rising demand for targeted therapies, according to DelveInsight.

“Key options include immunosuppressive drugs, investigational targeted therapies, and supportive measures such as ACE inhibitors or ARBs,” the report said.

In addition, ongoing clinical trial activities and the launch of emerging therapies are expected to further drive market growth.

The sector’s expansion is attributed to the rising prevalence of chronic kidney diseases and improved diagnostic capabilities.

Follow the link for more news on

Join Asian Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you design and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

What lies ahead for South Korea’s medical device market?
The government is investing over $622.1m to support next-generation medical devices.
Healthcare
Smart ports market to reach $15.5b by 2032
This will be driven by IoT, automation, and trade expansion.
China’s new coal power approvals decline in 9M
If this trend continues, 2025 will be the second-lowest year for approvals.

Exclusives

Singapore’s CNE plans over $1b push into Asian renewables
It’s working with banks on financing and will issue REITs to diversify funding sources.
Ciputra Life eyes more clients beyond group network
Rising health benefit demand is driving deeper ties with firms and banks. 
Indosat flags 290 million spam calls in 3 months
Its AI-driven system has shielded 11.5 million customers a month from fraud.